Krishan Kumar Thakur completed his Ph.D. in biosciences and bioengineering in September 2021 from the Indian Institute of Technology Guwahati, India. His Ph.D. work was primarily focused on the expression of lipocalin receptor in triple-negative breast cancer (TNBC). Through his research, Dr. Thakur showcased that lipocalin receptor is significantly upregulated in TNBC and leads to the tumorigenesis of the disease.
Dr. Thakur came to the NIH in November 2021 as a postdoctoral fellow to work with Dr. Pravitt Gourh in the Scleroderma Genomics and Health Disparities Unit of the NIAMS.
Dr. Thakur is interested in understanding the genetic risk factors involved in scleroderma pathogenesis. Moreover, he is studying the expression of transforming growth factor beta (TGF-β) and the role TGF-β plays in scleroderma pathogenesis.